Related by context. All words. (Click for frequent words.) 70 TLR8 70 MEK inhibitors 68 vascular disrupting agents 68 proteasome inhibitors 68 multitargeted 67 JAK2 inhibitors 67 novel peptide 67 molecular biomarkers 67 CDK inhibitors 66 siRNA therapeutics 66 neuronal nicotinic receptors NNRs 66 GPR# agonists 66 siRNA therapeutic 66 potent inhibitors 66 predictive biomarkers 66 kinase inhibition 66 anticancer therapeutics 66 Nanobodies 65 SARMs 65 therapeutic monoclonal antibody 65 NNR Therapeutics 65 kinase inhibitors 65 A3 adenosine receptor 65 Anticalins 65 IAP inhibitors 65 PI3K inhibitors 65 dAbs 65 Anticalin 65 HDAC inhibitors 65 antisense oligonucleotides 65 CB1 antagonists 65 molecularly targeted 65 antagomirs 64 Kinase inhibitors 64 therapeutic monoclonal antibodies 64 SGLT inhibitors 64 Squalamine 64 humanized monoclonal antibodies 64 epigenetic therapies 64 HDACs 64 selective inhibitors 64 ghrelin antagonist 64 preclinically 64 Nanobody ® 64 JAK inhibitor 64 preclinical compounds 64 Regado 64 Curaxins 64 antisense inhibitors 64 Onconase 64 DOS# 64 Epothilones 64 HIV integrase inhibitors 64 small molecule modulators 64 immunoregulatory 64 G Protein Coupled 63 deacetylase inhibitors 63 histone methyltransferases HMTs 63 JAK inhibitors 63 small molecule inhibitors 63 NTDDS 63 tubulin inhibitor 63 epigenetic enzymes 63 JAK2 inhibitor 63 Smac mimetics 63 aptamers 63 rxRNA compounds 63 telomerase inhibitors 63 anticancer compounds 63 renin inhibitors 63 druggable targets 63 antiviral compounds 63 investigational therapies 63 Anticalins R 63 cellular pathways 63 isoform selective 63 immune stimulatory 63 Preclinical studies suggest 63 small molecule agonists 63 GSK3B 63 histone deacetylase HDAC 63 protein kinases 63 Factor VIIa 63 small molecule activators 63 Locked Nucleic Acid LNA 63 Stapled Peptide 63 prolyl hydroxylase inhibitors 63 proteasome inhibitor 62 rxRNA 62 RNA therapeutics 62 Symadex 62 PDGF receptor 62 GPCR 62 JAK3 62 histone deacetylase 62 ENMD # 62 biologic therapeutics 62 mAbs 62 mimetics 62 Tyrima 62 splice variants 62 Hsp# inhibition 62 PI3K inhibitor 62 CCR2 62 ETBs 62 Sphingomab 62 Tarvacin TM 62 romazarit 62 kinase inhibitor 62 histone deacetylase HDAC inhibitors 62 cancer immunotherapies 62 CB2 selective 62 proprietary LNA 62 VEGF inhibitors 62 p# inhibitors 62 anticancer agents 62 LNP formulations 62 anti angiogenic drugs 62 immunotherapeutic 62 peptidic 62 immune modulating 62 diagnostic biomarkers 62 oligonucleotide therapeutics 62 humanized antibodies 62 immunoregulation 62 epothilone 62 enzyme inhibitors 62 GPR# agonist 62 cardiometabolic disorders 62 anti CD# antibodies 61 prognostic markers 61 PI3K/mTOR 61 histone deacetylase inhibitor 61 OMP #M# 61 telomerase activators 61 targeting PCSK9 61 biologic pathways 61 selective antagonists 61 tiapamil 61 OXIGON TM 61 immunotherapeutic approaches 61 Tarvacin Anti Viral 61 Dyax phage display 61 polyketides 61 GPCRs 61 Adnectin 61 FLT3 61 aptamer therapeutics 61 Receptors GPCRs 61 Xanafide 61 NNRs 61 Hsp# inhibitors 61 genetic biomarkers 61 AtuRNAi 61 monoclonals 61 chemopreventive agents 61 Nanobody 61 THR beta agonist 61 Kinases 61 epigenetic therapeutics 61 histone deacetylase inhibitors 61 prodrugs 61 nucleoside analogues 61 RNA antagonist 61 CB2 receptor 61 CTLA4 Ig 61 mGluR2 NAM 61 diagnostic biomarker 61 #ME# 61 pathogenic mechanisms 61 VDAs 61 fusion proteins 61 TLR8 agonist 61 adrenergic regulation 61 ddRNAi 61 RNAi therapeutic targeting 61 PDE4 inhibitor 61 HSP# inhibitors 61 ganaxolone 61 CCX# 61 TLR agonists 61 Archexin 61 therapeutic mAbs 61 Nanobodies ® 61 nicotinic alpha 7 60 clinically validated targets 60 medicinal chemists 60 geldanamycin 60 synthetic retinoid 60 orally administered inhibitor 60 M2 subunit 60 GDIR 60 mGluR5 antagonist 60 HCV protease inhibitors 60 coupled receptors GPCRs 60 NEUGENE 60 pharmacological chaperone 60 Novosom 60 telomerase inhibitor 60 anticoagulant reversing agent 60 ErbB3 HER3 60 potency selectivity 60 isoenzymes 60 investigational humanized monoclonal antibody 60 PDE# inhibitors 60 mTOR inhibitors 60 Curaxin 60 small molecule 60 beta secretase inhibitors 60 stranded LNA 60 HSP# inhibitor 60 tumor antigens 60 Pimavanserin 60 phosphorylated proteins 60 TRAIL receptor antibodies 60 Homspera TM 60 sigma receptors 60 polymerase inhibitors 60 therapeutic modalities 60 AEG# 60 5 HT2B receptor 60 ALK inhibitors 60 shRNA libraries 60 biomarkers 60 TRV# [001] 60 PARP inhibitors 60 Phylomer ® 60 cannabinor 60 GPR# [002] 60 TLR Therapeutics 60 glucagon receptor 60 CXCR4 receptor 60 MAbs 60 CORT # 60 Spiegelmer 60 TLR9 agonists 60 recombinant antibodies 60 p# inhibitor 60 novel anticancer 60 non nucleoside 60 phosphatases 60 Lpathomab 60 cytoprotective 60 peptide therapeutics 60 miRNA molecules 60 investigational monoclonal antibody 60 PORxin TM 60 Spiegelmer ® 60 multiplex assay 60 novel peptides 60 GPR# [001] 60 rxRNA TM compounds 60 NEUGENE R 60 resolvins 60 cathepsins 60 chemotypes 60 PARP inhibition 60 delafloxacin 60 TLR antagonists 60 peptidomimetic 60 targeting CD# 60 pharmacodynamic markers 60 CCR9 60 cell signaling pathways 60 NEUGENE antisense 60 siRNA compounds 60 immunological diseases 60 anti CD3 60 SGLT2 inhibitors 60 Isis antisense 60 Myolimus 60 siRNA sequences 60 Fibroblast Growth Factor Receptor 60 Kevetrin ™ 60 delta isoform 60 CMV vaccine 60 Aviptadil 60 P#X# 60 proprietary phage display 60 OxBC 59 subtype selective 59 CEQ# 59 brostallicin 59 immuno modulatory 59 Metallophile ™ Technology 59 ADME properties 59 MMP inhibitors 59 ALN TTR 59 melanocortin receptors 59 vivo potency 59 SIRT1 activators 59 PPARγ 59 Anticalins ® 59 VEGF receptor 59 DNAi 59 TÎ ² 4 59 treating neuropathic pain 59 tkRNAi technology 59 phosphate S1P 59 biomarker identification 59 genomic biomarkers 59 Panzem R 59 UsiRNAs 59 pharmacodynamic biomarkers 59 S#P# 59 personalized immunotherapy 59 IL# PE 59 ImmuneY2 59 selective kinase inhibitor 59 adenoviral 59 OvaRex R 59 humanised antibody 59 RNA antagonists 59 oncolytic viruses 59 IMPDH 59 oral anticancer 59 antisense drugs 59 chemopreventive agent 59 glucokinase activator 59 histone deacetylases 59 ProNAi 59 antitumoral 59 antimitotic 59 Panzem 59 anti fibrotic 59 ibudilast 59 nanoviricides 59 myelofibrosis polycythemia vera 59 engineered RAP peptides 59 synthetic peptides 59 peptide conjugated 59 5 HT2C 59 tyrosine kinase inhibitors 59 carbohydrate polymers 59 Hedgehog inhibitor 59 U1 Adaptors 59 Exelixis compounds 59 mda 7 59 protein kinase inhibitor 59 anticancer therapies 59 Spiegelmers ® 59 inhibit viral replication 59 VTAs 59 BCR ABL inhibitors 59 receptor tyrosine kinase inhibitor 59 monoclonal antibody therapeutics 59 Nektar proprietary 59 PSN# [002] 59 mTOR inhibition 59 humanized antibody 59 antimetastatic 59 protein tyrosine phosphatases 59 MAPK pathway 59 Celator 59 PDE# 59 orphan GPCRs 59 Zolinza 59 rxRNA ™ compounds 59 multi kinase inhibitor 59 Bendavia 59 inhibit EGFR 59 CobaCyte 59 ACTCellerate 59 hERG 59 echinocandins 59 cMET 59 integrin receptors 59 CRTH2 59 myeloproliferative disorders 59 ESBA# 59 DXL# 59 HGS# 59 mGluR4 59 mechanistic insights 59 peptide antigens 59 immunotherapeutics 59 Solazed TM 59 Phylomer 59 MEK inhibitor 59 LHRH antagonists 59 ALK inhibitor 59 Aurora kinases 59 fibrotic diseases 59 molecular abnormalities 59 secreted proteins 59 mimetic compounds 59 neuroprotective properties 59 Affibody ® molecules 59 inhibit angiogenesis 59 benzimidazole 59 small molecule defensin 59 orally bioavailable 59 antisense compounds 59 delipidation 59 enzyme inhibitor 59 endophenotypes 59 protein misfolding diseases 59 potently inhibit 59 Camptothecin 59 rNAPc2 59 Vilazodone 58 targeted radiotherapeutic 58 HepDirect 58 tyrosine kinase inhibitor 58 humanized monoclonal 58 CCR1 58 selective inhibition 58 non coding RNA 58 Personalized Immunotherapy 58 Anticalin R 58 Homspera 58 candidate deforolimus 58 Protein Kinase C 58 RhuDex TM 58 KLF4 58 Cytolin R 58 theranostic 58 eTag assays 58 JAK1 58 nucleotide analogs 58 peroxisome proliferator activated 58 RNAi therapeutic 58 cyclophilin inhibitor 58 brain penetrant 58 protein kinase inhibitors 58 heterocyclic 58 proliferative disorders 58 molecularly targeted therapies 58 Maxy G# 58 ARRY # 58 selective androgen receptor modulators 58 PARP inhibitor 58 cyclophilin inhibitors 58 IAP inhibitor 58 microRNA therapeutics 58 IGF 1R 58 Akt inhibitor 58 microRNA biomarkers 58 therapeutic modality 58 FGFs 58 SERMs 58 miR #b [002] 58 enhance ApoA 58 allosteric modulator 58 EndoTAG TM 58 rheumatoid arthritis multiple sclerosis 58 antisense inhibitor 58 IMA# 58 Pentad TM 58 peripherally acting 58 #beta HSD 1 58 Carfilzomib 58 MAXY VII 58 deforolimus 58 novel immunomodulatory 58 signaling cascades 58 preclinical efficacy 58 DCVax R 58 antisense 58 Cylene 58 Aegera 58 chemogenomics 58 phage display libraries 58 TLR9 agonist 58 antibody cytokine 58 radionuclide therapy 58 NS#/#A protease 58 antitumor 58 immunomodulation 58 AKT inhibitor 58 neuropsychiatric diseases 58 DPX Survivac 58 TG# [003] 58 CCR5 antagonists 58 reversible inhibitor 58 2 methoxyestradiol 58 anti secretory 58 thiazolides 58 SAR# [002] 58 Aurora kinase inhibitors 58 Vaccinex 58 γ secretase 58 cytochrome P# inhibition 58 pan HDAC inhibitor 58 Angiocept 58 ADAM# 58 BRAF inhibitor 58 novel antiviral therapeutics 58 glycolipids 58 Apo2L 58 KL4 surfactant 58 micro RNAs 58 NovaBay Aganocide compounds 58 TOCOSOL 58 GAP #B# 58 anti angiogenic agents 58 single stranded oligonucleotides 58 Aganocide 58 5 HT4 receptor 58 angiogenesis inhibition 58 HuLuc# 58 PI3K delta 58 chemokine receptors 58 drug conjugates 58 inhibit metastasis 58 sodium glucose transporter 58 intracellular signaling pathways 58 antisense drug 58 HCV antiviral 58 HepDirect R 58 reverse transcriptase inhibitors 58 nicotinic receptors 58 GSK# [002] 58 adenosine receptor 58 CB2 receptor selective 58 carbohydrate polymer 58 ophthalmology oncology 58 exon skipping 58 DiaKine 58 Sphingomab TM 58 adenosine A2A 58 midkine 58 Fleximer 58 tumor antigen 58 estrogen receptor beta 58 hormone gastrin 58 eIF 4E 58 immuno oncology 58 Sym# 58 ONCONASE R 58 Posiphen TM 58 URG# 58 anti amnesic 58 AMPK activators 58 interferon lambda 58 Anidulafungin 58 Aurora kinase inhibitor 58 molecular imaging radiopharmaceuticals 58 agonist compounds 58 Spiegelmers R 58 serine proteases 58 Anti angiogenic 58 HDACi 58 ErbB3 58 pharmacophore 58 nonviral 58 R#/MEM # 58 muscular dystrophies 58 Dr. Pasinetti 58 IgG1 antibody 58 Cathepsin S 58 lymphoid tumors 58 synthetic siRNA 58 GKAs 58 E#F# 58 metabolic enzymes 58 Trofex 58 gastro intestinal inflammation 58 CXCR7 58 HDAC inhibitor 58 immunomodulatory properties 58 PDE7 58 Lisofylline LSF 58 OGeS 58 peptides 58 alpha7 58 sirtuin therapeutics 58 murine antibodies 58 PDE4 inhibitors 58 potent anticancer 57 PDE7 inhibitors 57 XmAb# 57 validate biomarkers 57 myeloma cells 57 kinases 57 druggable 57 kinase profiling 57 transgenic mouse models 57 antiviral therapies 57 myeloproliferative diseases 57 novel anti infective 57 phage display 57 HCV protease 57 atopic march 57 nucleoside analogs 57 chemokine receptor 57 ZFPs 57 Janus Kinase 57 chimeric monoclonal antibody 57 drug metabolizing enzymes 57 antiangiogenesis 57 endogenous ligands 57 NITD# 57 biobetter 57 Viprovex TM 57 Azedra 57 cytotoxic agents 57 prophylactic vaccine 57 splice variant 57 NP2 Enkephalin 57 isoform selective inhibitors 57 BRAF inhibitors 57 KineMed 57 pharmacologic approaches 57 cytostatic 57 activate SIRT1 57 RNAi therapeutic targeting PCSK9 57 glucocorticoid receptor 57 EGFR inhibitors 57 estrogen receptor modulators 57 Anticalin ® 57 EP #R 57 IMC #B 57 tRNA synthetases 57 biomarker assays 57 GelSite R polymer 57 immunogens 57 acamprosate prodrug 57 receptor antagonists 57 Janus kinase 57 mGluR5 antagonists 57 somatostatin analogue 57 enkephalin 57 PPARg 57 lysosomal storage disorders 57 BiTE 57 Guanilib 57 Zybrestat 57 Cyclosert 57 antiangiogenic 57 deacetylase 57 SGLT 2 57 INS# [001] 57 selective immunoproteasome inhibitor 57 CENP E 57 selective kinase inhibitors 57 HDAC inhibition 57 investigational compounds 57 CCR3 57 candidate CRLX# 57 ALN PCS 57 tkRNAi 57 sphingolipids 57 Th2 cytokines 57 #HT#A 57 Syllego system 57 AMPAKINE compounds 57 topical formulations 57 otelixizumab 57 vascular disrupting agent 57 metabonomics 57 Antisense 57 molecular underpinnings 57 miRNA biomarkers 57 MAb 57 teplizumab 57 Tß4 57 sirtuin inhibitors 57 therapeutical 57 predictive toxicology 57 antitumor effects 57 metalloenzymes 57 vivo validation 57 polymer conjugate technology 57 JAK2 57 DermaVir 57 HDAC enzyme 57 Chemokine Receptor 57 Pentraxin 2 57 aptamer 57 endothelin antagonist 57 isotypes 57 USP# 57 HQK 57 Mipomersen 57 ADAMTS# 57 Synavive ™ 57 short interfering RNA 57 lipopeptide 57 AT1R 57 breast cancer subtypes 57 effector function 57 DNA methylation biomarkers 57 K ras mutations 57 microRNAs miRNAs 57 HuCAL antibody 57 immunomodulatory 57 serine protease 57 siRNAs targeting 57 radiolabeled 57 AMPAKINE 57 Micromet BiTE 57 Chrysalin 57 c MET 57 mitotic kinesin 57 Davanat 57 Phase IIb clinical trials 57 fusion enhancers 57 integrative pharmacology 57 EGFR HER 57 molecular profiling 57 aurora kinase 57 gamete formation 57 HDAC enzymes 57 fatty acid biosynthesis 57 mGlu2 3 57 Olaparib 57 epothilones 57 ligases 57 PEG SN# 57 physiologic mechanisms 57 lysophosphatidic acid LPA 57 hypoxia activated prodrug 57 5 HT2A receptor 57 selective androgen receptor modulator 57 eprotirome 57 Lixivaptan 57 angiogenesis inhibitors 57 Angiolix 57 immune modulator 57 chemopreventive 57 Euroscreen 57 KSP inhibitor 57 ADME Tox 57 genetic loci 57 bioactive lipids 57 tranilast 57 potent antiproliferative 57 LY# [003] 57 antibody therapeutics 57 thalidomide Thalomid 57 talabostat 57 C5aR 57 Aganocide ® 57 cytochromes P# 57 HERmark assay 57 COX enzymes 57 undruggable targets 57 Receptos 57 underlying molecular mechanisms 57 Factor Receptor 57 biochemical mechanisms 57 PI3 kinase 57 CETP inhibitors 57 cancer immunotherapy 57 OX1 57 immunotoxins 57 therapeutic regimens 57 HDL Mimetic Peptide 57 XL# XL# 57 pharmacologic intervention 57 Onalta ™ 57 multiplexed assays 57 TLR9 57 posttranslational modifications 57 rolapitant 57 iPSC technology 57 Zacharon 57 phage display technology 57 vidofludimus 57 vaccine GRNVAC1 57 DermaVir Patch 57 beta interferons 57 direct thrombin inhibitors 57 novel orally bioavailable 57 Pancreate 57 ncRNA 57 novel antibody therapeutics 57 diagnostic molecular imaging 57 antiangiogenic drugs 57 bioactive lipid 57 prognostic biomarkers 57 AVI NEUGENE 57 favorable pharmacokinetic 57 antiproliferative effects 57 cationic lipid 57 Protease inhibitors 57 allosteric 57 antithrombotic 57 pro angiogenic 56 therapeutic 56 chemically modified tetracyclines 56 Chimigen TM 56 pexiganan 56 immuno inflammatory 56 Notch receptors 56 CYT# potent vascular disrupting 56 oral taxane 56 causative genes 56 PI3 kinase inhibitors 56 peptides proteins 56 ASONEP 56 antiangiogenic agents 56 vivo pharmacology 56 Survivin 56 BHT DNA 56 Nanobody R 56 reuptake inhibitors 56 AKT1 56 PI3K 56 tumor subtypes 56 proteases 56 protein misfolding 56 Immunotherapeutic 56 Anavex #-# 56 TOCOSOL Camptothecin 56 ATL# [002] 56 orally dosed 56 short hairpin RNAs 56 oral prodrug 56 Aurora kinase 56 CCR9 antagonist 56 partial agonists 56 VitiGam 56 systemic RNAi 56 IGF IR 56 rBChE 56 Neurodegenerative diseases 56 antibody fragment 56 immune modulation 56 Interferon alpha 56 stapled peptides 56 Aurora Kinase 56 kallikrein 56 5 HT6 receptor 56 compound AEZS 56 antitumour 56 macrocycles 56 proliferative diseases 56 mitochondrial toxicity 56 LEX System 56 secreted protein 56 ocular formulation 56 microRNA molecules 56 neuroinflammation 56 intracellular protein 56 partial agonist 56 cholesteryl ester transfer 56 Gleevec inhibits 56 Flt3 56 epigenetic regulation 56 pharmacokinetic interactions 56 SMT C# 56 mecamylamine 56 peptide ligands 56 oncoproteins 56 pathophysiologic mechanism 56 Wnt signaling pathway 56 shRNAs 56 humanized monoclonal antibody 56 FGFR 56 insulin sensitizer 56 ophthalmic diseases 56 NS5A 56 synthetic lethality 56 triterpenoids 56 stable nucleic acid 56 Insegia 56 Fabry Disease 56 biomarker assay 56 acadesine 56 miRNA therapeutics 56 coupled receptor GPCR 56 interleukins 56 Vegenics 56 transient receptor 56 DNA gyrase 56 PKC isoforms 56 noncoding RNA 56 LEP ETU 56 NS4B 56 HepeX B 56 inhibit KSP 56 protein kinase C 56 targeted antifolate 56 inverse agonist 56 ALN TTR# 56 Micro RNAs 56 pharmacogenetic test 56 mitotic kinesins 56 GABAB receptors 56 dipeptidyl peptidase IV 56 EGFR tyrosine kinase inhibitors 56 VIPR2 56 humanised monoclonal antibody 56 inactivating mutations 56 CCR5 antagonist 56 tumor hypoxia 56 Epidermal Growth Factor Receptor 56 miR #a [002] 56 JAK#/JAK# 56 REP# 56 immunomodulators 56 TRP channels 56 polysaccharide polymer 56 ALV# 56 prognostic marker 56 pharmacogenomic tests 56 selectively inhibits 56 morpholino 56 Deforolimus 56 Dapagliflozin 56 signal transduction inhibitors 56 microtubule inhibitor 56 Multimeric 56 Ridaforolimus 56 HTRF 56 ART# 56 oral PTH 56 immunotherapeutic vaccine 56 oncogenesis 56 Exelixis XL# 56 selective antagonist 56 JUVISTA R Human 56 Panzem ® 56 beta defensins 56 radezolid 56 VeraTag assays 56 immuno inflammatory diseases 56 genomics proteomics 56 Pertuzumab 56 TLE3 56 MCSP respectively 56 non nucleoside HCV 56 FK# 56 OncoVEX 56 VasoGenix 56 Smac mimetic 56 ProLindac TM 56 therapeutics 56 HyACT 56 neurotrophic 56 Surfaxin LS 56 proteins peptides 56 angiogenesis inhibitor 56 irinotecan oxaliplatin 56 HCV replication 56 Src inhibitors 56 ligand binding 56 EGF receptor 56 pyrimidines 56 genomic profiling 56 fibrotic disease 56 HepDirect technology 56 Locked Nucleic Acid 56 flavopiridol 56 genetic determinants 56 OncoMed 56 Tr DNA 56 CORT # estimates 56 Quark Biotech Inc. 56 neuroactive 56 ubiquitin ligases 56 INT# [002] 56 micro RNA 56 ANGPTL4 56 NF kB pathway 56 antibody 56 NPC 1C 56 GRN#L 56 CCR5 inhibitors 56 iPS derived 56 costimulation 56 ophthalmic indications 56 stem cell therapeutics 56 disease modifying 56 RhuDex ® 56 selectively inhibit 56 TKM ApoB 56 galectin 56 HCV protease inhibitor 56 immunotoxin 56 therapeutic peptide 56 Pathway Inhibitor 56 pharmacogenetics 56 anti miRs 56 5 HT2C serotonin 56 Rasagiline 56 HCV polymerase inhibitors 56 kidney urologic 56 Factor Xa 56 nucleosides 56 opioid receptor antagonist 56 selective modulator 56 neuro protective 56 Cardio Vascu Grow 56 CDP# 56 TKB# 56 enzyme cofactor 56 presymptomatic 56 tyrosine kinases 56 prostone 56 skeletal muscle contractility 56 genomic biomarker 56 tezampanel NGX# 56 huC# DM4 56 GSOs 56 NNR subtypes 56 Quark Biotech